26 June 2026
26 June 2026
Former FDA employees discussed whether the agency’s commitment to openness risks creating a lack of clarity on official policies.
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Ionis has forecast peak sales of $2bn for Tryngolza as it seeks to harness first-mover advantage.
Amid the debut of positive Phase I data, the biotech will push its lead asset further down the clinical pipeline in endometriosis and pattern hair loss.
The collaboration will see the companies gather and analyse data from many patient samples.
Recordati will handle regulatory filings and commercial operations ex-US, including supporting early access initiatives.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
